A carregar...

Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19

Majority of patients infected with the COVID 19 virus display a mild to moderate course of disease and spontaneously recover at 14–20 days. However, about 15% of patients progress to severe stages and 2.5% of these patients succumb to this illness. Most patients with severe disease belong to the eld...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med Hypotheses
Main Authors: Rao, Vishal, Thakur, Shalini, Rao, Jyothsna, Arakeri, Gururaj, Brennan, Peter A., Jadhav, Sachin, Sayeed, Mufti Suhail, Rao, Gururaj
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier Ltd. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7232064/
https://ncbi.nlm.nih.gov/pubmed/32425307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.109845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!